Effect of 15-deoxyspergualine on antigen-specific lymphocyte activation measured by CD69 expression.
Maitre
N
N
Department of Molecular Biology, Medical University of South Carolina, Charleston 29425-2230, USA.
Goust
J M
JM
D015703:Antigens, CD / Q000378:metabolism*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000378:metabolism*; D004768:Enterotoxins / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D037181:Lectins, C-Type; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology*; D018089:Superantigens / Q000494:pharmacology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013745:Tetanus Toxoid / Q000494:pharmacology; D000099192:CD69 Antigens
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D004768:Enterotoxins; D006146:Guanidines; D007166:Immunosuppressive Agents; D037181:Lectins, C-Type; D018089:Superantigens; D013745:Tetanus Toxoid; D000099192:CD69 Antigens; C031818:enterotoxin B, staphylococcal; C037258:gusperimus